These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 433601)

  • 61. Persistent complement activation on tumor cells in breast cancer.
    Niculescu F; Rus HG; Retegan M; Vlaicu R
    Am J Pathol; 1992 May; 140(5):1039-43. PubMed ID: 1374587
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway.
    Wisnieski JJ; Todd EW; Fuller RK; Jones PK; Dearborn DG; Boat TF; Naff GB
    Am Rev Respir Dis; 1985 Oct; 132(4):770-6. PubMed ID: 3850731
    [TBL] [Abstract][Full Text] [Related]  

  • 63. C3 polymorphism in a Danish cystic fibrosis population and its possible association with antibody response.
    Schiøtz PO; Høiby N; Morling N; Sørensen H
    Hum Hered; 1978; 28(4):293-300. PubMed ID: 658974
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis.
    Brogan TD; Ryley HC; Neale L; Yassa J
    Thorax; 1975 Feb; 30(1):72-9. PubMed ID: 47656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection.
    Kharazmi A; Rechnitzer C; Schiøtz PO; Jensen T; Baek L; Høiby N
    Eur J Clin Invest; 1987 Jun; 17(3):256-61. PubMed ID: 3040421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Component concentrations and activation of the complement system in neonatal illness: a preliminary study of necrotizing enterocolitis.
    Stevenson DK; Hsu YP; McMorrow M; Berseth CL; Neu J; Miller JJ
    Eur J Pediatr; 1980 Sep; 134(3):255-9. PubMed ID: 7053192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor.
    Dwyer M; Shan Q; D'Ortona S; Maurer R; Mitchell R; Olesen H; Thiel S; Huebner J; Gadjeva M
    J Innate Immun; 2014; 6(6):765-79. PubMed ID: 24862346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunofluorescence studies of lung tissue in cystic fibrosis.
    Tomashefski JF; Abramowsky CR; Chung-Park M; Wisniewska J; Bruce MC
    Pediatr Pathol; 1992; 12(3):313-24. PubMed ID: 1409135
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pulmonary inflammation in cystic fibrosis].
    Bui S; Boisserie-Lacroix V; Ceccato F; Clouzeau H; Debeleix S; Fayon M
    Arch Pediatr; 2012 May; 19 Suppl 1():S8-12. PubMed ID: 22682493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune complexes in cystic fibrosis.
    McFarlane H; Holzel A; Brenchley P; Allan JD; Wallwork JC; Singer BE; Worsley B
    Br Med J; 1975 Feb; 1(5955):423-8. PubMed ID: 1090336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Letter: C3 in cystic fibrosis.
    Scanlin TF; Norman ME; Rosenlund ML
    Lancet; 1975 Jun; 1(7921):1382. PubMed ID: 48969
    [No Abstract]   [Full Text] [Related]  

  • 72. A functionally active complement system is present in uterine secretion of the mouse prior to implantation.
    Jin M; Larsson A; Nilsson BO
    Am J Reprod Immunol; 1991 Sep; 26(2):53-7. PubMed ID: 1768317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?
    Labiris NR; Nahmias C; Freitag AP; Thompson ML; Dolovich MB
    Eur Respir J; 2003 May; 21(5):848-54. PubMed ID: 12765432
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of hypoxia in children with cystic fibrosis.
    Urquhart DS; Montgomery H; Jaffé A
    Arch Dis Child; 2005 Nov; 90(11):1138-43. PubMed ID: 16243867
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor markers CA 19-9 and CA 195 are also useful as markers for cystic fibrosis.
    Wu JT; Olson J; Walker K
    J Clin Lab Anal; 1992; 6(3):151-61. PubMed ID: 1506983
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Complement activation in pneumonia.
    Nydegger U; Farquet JJ; Zubler R; Lambert PH; Miescher PA
    Med Microbiol Immunol; 1979; 167(4):261-8. PubMed ID: 397408
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The inhibition of superoxide production by the soluble phase of cystic fibrosis sputum.
    Dosanjh A
    Open Respir Med J; 2008; 2():80-3. PubMed ID: 19365536
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Precipitins to Klebsiella and other enterobacteria in the serum of patients with chronic respiratory disorders.
    Burns MW
    Lancet; 1968 Feb; 1(7539):383-5. PubMed ID: 4169973
    [No Abstract]   [Full Text] [Related]  

  • 79. Carboxypeptidase B-like activity and C3 in cystic fibrosis.
    Lieberman J
    Am Rev Respir Dis; 1975 Jan; 111(1):100-2. PubMed ID: 803353
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrathecal synthesis of complement components C3c and C4 in the central nervous system infections with signs of the acute serous meningitis syndrome.
    Tatomirović Z; Bokun R; Bokonjić D
    Vojnosanit Pregl; 2002; 59(3):265-70. PubMed ID: 12132240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.